Â
Trading ideas and investment strategies discussed herein may give rise to significant risk and are not suitable for all investors. Investors should have experience in relevant markets and the financial resources to absorb any losses arising from applying these ideas or strategies.
BofA Securities does and seeks to do business with issuers covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.
Key takeaways
- Growth concerns support constructive duration stance; stay dip buying. Fed likely to cut 25bp next week; dots likely hawkish
- Lack of dovish tilt from ECB leaves the front-end vulnerable. BoE QT decision will be important beyond the Gilt supply impact
- In AU, higher fiscal deficits should tighten swap spreads. We expect BoJ to reduce purchases of sub-10y JGBs in Oct-Dec
Â
The View: From one come many
After the ECB this week, next week sees the FOMC, BoE, BoJ and Norges. We expect the FOMC to cut by 25 bp, the BoE and BoJ to remain on hold. Focus on rinban in Japan.
 ─ R. Preusser
Rates: Another one bites the cuts
US: Growth concerns support constructive duration stance; stay dip buying. Fed likely to cut 25bps next week; dots likely hawkish vs market but not Powell.
EU: The lack of dovish tilt from the ECB leaves the front-end vulnerable to moves in other markets. We highlight our X-market positions as alternative to outright positions.
UK: BoE QT decision will be important beyond the Gilt supply impact: for debt definition, Gilt liquidity considerations & relative scarcity of low coupon Gilts.
AU: Higher fiscal deficits should tighten swap spreads but recent tightening has overshot our estimate of fair value. Wait for a spike in 10y spreads to c. 15-20bps before receiving.
JP: We expect BoJ to reduce purchases of sub-10yr JGBs in Oct-Dec, while maintaining purchase sizes for superlong JGBs.
 ─ M. Cabana, M. Swiber, B. Braizinha, R. Axel, S. Salim, A. Stengeryte, M. Capleton, O. Levingston, T. Yamashita, S. Yamada
ÂFront end: US funding & debt limit: Sept '24 update
US: Debt limit client questions rising, we update our projections. X-date should be in in summer '25, July now most likely.
EU: We expect the Eurosystem balance sheet to fall to €6.4trn by end-2024; we stay paid EUR FX-Sofr basis and close our 2y 3s6s widener.
 ─ M. Cabana, K. Craig, R. Man
Technicals: US 2Y & 30Y yield teetering on a cliff edge
US 2Y yield tests 3.55% (its 2023 low) and US 30Y yield test 3.94% (it's 52wk low). These levels, if broken, could extend the decline in US yields in H2.
 ─ P. Ciana
Â
 Our medium term views
 Our key forecasts
  What we like right now
Â
  The View
Â
Â
 The week that will be
Next week's main event will be the FOMC meeting. At the time of writing, markets are pricing just over 25 bp of cuts for Wednesday - in line with our economists' call - from last Friday's intra-day high of 43 bp.
Our core convictions remain unchanged: even in a soft landing scenario markets will struggle to reduce meaningfully the implied hard landing risk premium. This is likely to leave rates trading somewhat rich, especially in the front-end of the curve. There is room for the curve to steepen, but we continue to favor 5s30s over 2s10s (see Liquid Insight 9 Sep 24). However, with markets still holding onto a deep trough in the cutting cycle, we see tactical value in bear flatteners (see Rates US).
With the FOMC out of the way markets will turn to the BoE. Crucially, we receive inflation data on Wednesday, ahead of the BoE on Thursday. Our economists expect the BoE to be on hold and worry that core inflation may actually pick up a bit in the August print also strengthening the case for patience. We are paid 3s5s7s Sonia and short UK 5y real yields, outright and cross market (see UK Rates Viewpoint 5 Sep 24).
Next, we have the BoJ decision. Our economists do not expect a rate hike before the end of the year, so more relevant for markets could be the interplay between issuance and BoJ purchases (see Rates Japan). We expect the BoJ to reduce purchases of JGBs with maturities up to 10 years and maintain the purchase sizes for superlongs in the Oct-Dec Rinban operations. At the same time the Ministry of Finance shortened issuance at its liquidity enhancement auctions in August, which could be included also in the FY25 JGB issuance plan. We see scope for 10s30s to flatten.
In the Euro Area, the main data of note beyond ZEW could be the details of the August inflation print, as well as the July current account data. The current account data could be a useful reminder that the EA is structurally saving more than pre-pandemic.
The weeks that were
Following last week's payroll print, our economists revised their forecasts for the Fed to consecutive 25 bp cuts (see Federal Reserve Watch 6 Sep 24). The CPI print was not weak enough to sustain hopes of a 50 bp cut (see US Watch 11 Sep 24).
The ECB meanwhile was not dovish enough for markets. 2y German yields are up 7bp on the day and the 2y-30y curve is 4bp flatter. While we believe the ECB has left the door wide open to a cut in October, we see the front-end of the curve as vulnerable and likely to be driven more by priced action in the US and UK, now that the ECB has failed to provide another impetus to the rally. We stay long 2y1y, long cross market and long 30y.
Â
  Rates - US
Â
Â
- Â Â Â Â Â Growth concerns support constructive duration stance; stay dip buying
- Fed likely to cut 25bps next week; dots likely hawkish vs market but not Powell
Growth jitters & debate bait
US rates declined & the UST bull steepened with building downside growth risks. Downside risks stemmed moderating NFP & bank guidance (Ally = worsening consumer, JPM = lower NII). These concerns may have been furthered by market perception Fed cuts won't be fast enough, esp. with sticky core CPI & OER; Waller hinted at 25bps next week & a willingness to speed up if needed, which pushed cuts into the Dec '24 & later (Exhibit 4). Small shifts in election probabilities post-debate may have also pared back further fiscal easing expectations (Exhibit 5). On net, growth concerns pushed credit spreads modestly wider, cross market implied vol slightly higher, & rates lower.
On balance, developments this week did little to change our core views around duration & curve. Duration: we still recommend clients buy the rate dip & add duration exposure on any back up in rates. Our preferred place to add is the belly (5y) given it best represents the Fed cutting trough & is relatively agnostic on the exact Fed cutting path. Curve: we still hold 5s30s nominal steepeners given US growth moderation, Fed cuts, & long end supply / demand concerns. Our recent work highlighted duration & curve trades at the first Fed cut historically outperform forwards (see FAQ: Fed cuts & US rates).
Fed likely to find neutral from below
Fed cuts are very well priced with the trough at 2.85%. The trough is now priced so low because the market anticipates the Fed cutting below neutral to stimulate activity. This contrasts to market pricing at the June FOMC meeting, which expected Fed cuts only to neutral (Exhibit 6). The deeper trough aligns with increased downside growth risks.
We are sympathetic to the market's interpretation of Fed reaction function. The Fed does not know where neutral is & will only discover it by relying on feedback from economic data & financial conditions. The market expects the Fed will likely find neutral from below (over cutting) vs find neutral from above (under cutting). A shift to finding neutral from below is also consistent with increased focus on downside growth risks.
A significant number of investors see some overpricing of the Fed near-term. In a back-of-the-envelope calculation, if hard landing scenarios are consistent with 150bp worth of cuts by end-'25, and soft-landing c.50-75bp, the c100-105bp of cuts the market is pricing corresponds to a c.35-40% likelihood of hard landing. We recently recommended US 1y2y OTM payers vs EU 1y2y payers (see US Rates Alpha from 8 Sep '24), and the position is likely to perform well in scenarios where the market fades some of the near-term Fed pricing. Bear flatteners also leverage this type of scenario, and we favor expressing the view thought a long 3m2y payer spread atm/atm+25bp fully financed by selling 3m10y atm+20bp payers. The trade works as a proxy for a bear flattener but avoids the current giveup to forwards in those positions. Carry is positive by c.4bp/m. The main risk on the position is a bear steepening scenario with potentially unlimited downside. The position is also expose to parallel selloffs of more than 25bp.
FOMC: hawkish dots, dovish Powell
The Fed will cut 25bps next week & release a new Summary of Economic Projections. Our economists expect the dots to show total cuts of 75bps in '24, 125bps in '25, 50bps in '26, & none in '27. These dot plot expectations are much more hawkish vs market pricing (Exhibit 7). Rates may initially rise with the dots; we suggest fading the move.
Powell is likely to sound dovish in his press conference. He should highlight downside risks to the labor market & willingness to speed up the pace of rate cuts if needed. Powell will reiterate data dependence but flag downside growth risks. On balance, we expect the market to interpret the Sept FOMC as delivering a neutral to dovish cut.
Regulatory *Barr* lowered
Fed Vice Chair of Supervision Michael Barr gave an outline of the revamped proposal of the Basel 3 (B3) endgame guidelines this week. We do not believe it is a game changer but it may reduce costs and frictions in Treasury markets (lower capital need vs original proposal, GSIB surcharge co-efficient shifts). The reg shift is not enough to change our negative view on spreads. Reduced capital needs should be mildly supportive of swap spreads but the larger underlying theme of heavy Treasury supply should continue to be a main driver of cheaper Treasuries over time, despite the B3 endgame revamp.
Importantly, the B3 endgame shift hints at a new wave of increased private-public partnership in crafting bank and market regulations. As the financial system and regulatory landscape become increasingly complex, the web of interacting regulations, markets and end-users appears to require increasing collaboration between policy makers and stakeholders. We see the B3 rewrite as a more collaborative effort that could set an example for future regulatory changes (see: Basel 3 endgame shaping up).
Bottom line: growth concerns support a constructive duration stance; we hold our existing steepener recommendations. Fed will cut 25bps; dots may be hawkish vs market but Powell likely won't be. For clients who think too many cuts we recommend cross market expressions or bear flatteners in options space.
  Rates - EU
Â
Â
- Given the significant rally in the past two weeks, the lack of dovish tilt from the ECB leaves the front-end vulnerable to moves in other markets in the very short term.
- Investors concerned about an insufficiently dovish Fed should consider our EUR cross market trades, with our received 2y1y €str position temporarily at risk.
Taking stock of investor views and ECB meeting
Markets converging to our baseline…
The last few weeks have seen a clear shift in market narrative. Our investor meetings and the just-released monthly FX and rates sentiment survey, 13-Sep indicate that views around inflation and terminal rate have started to meaningfully converged towards our economists' baseline: sub 2% inflation in the medium term (Exhibit 8) and sub 2% ECB terminal (Exhibit 9). A reduced number of investors challenge our view that the neutral rate in the Euro area may not have moved higher from pre-Covid.
The reduced expectations around a potential fiscal shift, towards more supportive policies, are possibly helping the reassessment of the Euro Area neutral (Exhibit 10). The market implied terminal rate has dropped from 2.05% to c.1.75% (pre ECB), finally reacting more forcefully to the front loading of cuts that started to be priced in Jul-Aug.Â
Â
… But ECB leaves the front end vulnerable near term.
However, now that the ECB has failed to provide another impetus to the rally, the front-end of the curve appears vulnerable to moves in other markets over the very short term.
- ECB messaging: no dovish tilt, with low Sep inflation already noted
The ECB delivered the expected 25bp cut but kept the same message of data-dependence and meeting-by-meeting approach. There was no clear dovish tilt. ECB president Lagarde was careful not to provide any signal on the timing or pace of future decisions. She insisted that the cut was only a "step" again, which our economists interpret as as not being clearly on a normalization path yet. If anything, one could
take her comments on looking through the likely weak inflation print in September or her renewed emphasis on the December forecast as very soft signals that an October cut is a difficult proposition (see full ECB review: Que será, será? Será late).
- Positioning is in steepeners
Our investor conversations over the past two weeks indicate a clear and strong consensus on curve steepeners, both in EUR and US rates. This is also something flagged in the work that our US colleagues conduct on flows (US rates watch, 9-Sep).
- Lack of confidence on pace of near-term cuts
When it comes to the amount of cuts currently priced in the very front-end (2024), around one third of investors believe that this is exaggerated but are just not fading it at the moment (Exhibit 11). The messaging from other central banks could change that.
Favor cross market trades if concerned
We continue to hold our 2y1y €str received position as a long-term structural trade, recommended on Sep 3rd (entry: 2.12%, current: 1.9%, target: 1.7%, stop: 2.4%). The main risks are better than expected data or a pricing out of global CB cuts. Still, given the above, we argue that investors concerned about an insufficiently dovish Fed next week or a hawkish BoE should consider the X-market trades we recently recommended:
- Long OTM US 1y2y payers funded by ATM 1y2y payers in EUR. From a mark to market perspective, the risk to these positions is an overly dovish Fed that leads to further outperformance of US rates. From a terminal point of view, the risk would be more persistent EZ inflation, resulting in a larger sell-off in EUR rates.
- Received 3y1y €str vs paid 3y1y CAD OIS (current: 32bp, target: 80bp, stop: 15bp). The divergence in terms of cuts priced between the two central banks is most significant in 3y1y, with the market pricing in that the BoC would extend the cuts to 2.35% (BofA baseline: 3%). The risk to the trade is weak Canadian / US data.
- Receive 5y real rate in EUR vs UK (current: 53bp, target: -40, stop: 90bp). Our inflation strategist entered the trade to position for (1) larger UK short-dated issuance, (2) inflation risks limiting BoE cuts vs ECB, (3) UK's deteriorating IIP/GDP ratio vs the EZ (see note: Liquid Insight 21-Aug). The main risk is a dovish BoE.
We also remain bullish the back end of the EUR curve, with a long 30y Bund position - current: 2.42%, target: 2%, stop: 2.83%. There, positioning is lighter, and supply will be declining. Support can also emerge from structural receiving flows and the macro thematic of a central bank behind the curve. The main risk is reduced PF demand.
Â
 Rates - UK
Â
Â
- BoE QT decision will be important beyond the Gilt supply impact: for debt definition, Gilt liquidity considerations & relative scarcity of low coupon Gilts.
 Quantitative Tinkering
The UK rates market's advance since the start of the month resulted in two 25bp rate cuts being fully priced in by year-end for the first time since early August (Exhibit 12). Sonia swaps now imply 165bp of cuts by year-end 2025 and a 3.17% terminal rate by September 2028 (Exhibit 13). When compared with our forecasts, the market now prices a faster rate cutting cycle (than our expected quarterly pace) and a fractionally lower terminal rate (our base case is 3.25%).
After mixed labour market and growth data, the inflation numbers are the only potentially influential prints remaining before the 19 September rate decision (see Labour market: Healthy employment, 10 September and GDP: Flat, 11 September). Â Our economists expect the MPC to remain on hold next week - in line with market pricing - after a finely-balanced decision to cut in August (with the MPC's Chief Economist dissenting) and with inflation persistence concerns to the fore. We expect a slower-than-priced easing cycle with these concerns proving slow to subside.
Our preferred way to position remains via Sonia 3s5s7s fly (pay belly, receive wings). The trade should benefit from pricing out of the rate cutting speed expected by the market. Our conviction is higher for the balance of 2024: we expect cuts in one of the three meetings while the market expects two; two are possible, but one appears much more likely than three (every meeting), in our view. We also expect the fly to benefit from shifting UK banks' flows from structural receiving to mortgage paying (see Back to school: tough tests this term, 5 September). We entered the trade at -12bp with a target of 10bp and a stop at -21bp. Current level is -12bp. Risk to the trade is UK government increasing Stamp Duty tax at the Budget, slowing housing market activity (see BoE preview: Hold with unchanged guidance, 13 September).
 Many ways in which QT decision matters
 The BoE's target for the APF Gilt stock reduction over the year from October, and its Gilt sales schedule for 4Q24, should be announced alongside the September MPC decision. Our assumption is that the vote will be to reduce the stock by £100bn over the year, requiring £13bn of active Gilt sales. However, the Bank's expressed confidence in QT's progress "in the background", as expressed in August's MPR, hints at upside risks.
We assume the BoE will hold one Gilt auction per month to achieve its £13bn active QT target. With the Bank now targeting sales evenly across maturity sectors, but measured in initial proceeds terms, we expect the 4Q24 auction schedule to feature a £0.9bn auction of short Gilts in October, a £0.6bn auction of longs in November and a £0.8bn auction of mediums in December. There are of course many ways the BoE could conduct this £13bn of active QT. For more on Gilt supply from the DMO and BoE combined, see Gilt supply in 4Q24: modestly lighter but upside risks beyond October, 3 September. Â
Beyond the Gilt supply to the market, the QT decision will be important in other ways:
-  Debt definition considerations: BoE losses crystalised on QT sales and redemptions are incorporated in the debt measure that the previous Conservative government used in its fiscal rules (PSND ex BoE). The Labour government can change the debt measure used in its fiscal rules in the October budget to reduce (or potentially even remove) the impact of these losses. If it doesn't, the QT decision could have implications for the OBR's assumption for the future QT pace and hence the fiscal space. Currently, the OBR assumes £48bn of active sales per QT year (the amount done in 2023/24) and total QT to fluctuate each year based on the uneven profile of redemptions. Our £100bn/year scenario would reduce QT losses expected in the near term.
- Â Gilt liquidity considerations: The QT decision might also matter in the context of deteriorating Gilt liquidity relative to USTs and Bunds (Exhibit 14). Calls for the Bank to sell sub-3y Gilts have resurfaced. This is something we have recommended for a long time - for instance, last December we said: "We do think there are strong reasons for adjusting the buckets, selling fewer long Gilts and introducing sales of 1-3y Gilts" (see Liquid Insight, 6 December 2023). This would improve liquidity in scarcer issues, reflect the reality that the Bank's portfolio has shortened a lot and smooth the transition away from an abundant liquidity regime (by providing banks with more desirable HQLA).
-  Relative scarcity of low coupon Gilts: It was noteworthy that BoE sales of short-dated Gilts in July (two £800mn ops, 15 July and 29 July) saw £1.1bn of the operation size (in market value terms) being purchases of UKT 0.125% 2028, with most of other Gilts acquired in that operation also low coupon issues. In August, the one short-dated Gilt sale saw £0.63bn allocated to UKT 0.125% 2028 (Exhibit 15). If we are right that BoE sticks with £100bn QT - implying £900m short Gilt sales per quarter by our estimates - then that potential source of low coupon Gilts will slow to a trickle.
The last point is one of the factors that will influence low coupon/high coupon Gilt spreads (another being potential changes in appeal following the Budget). Another is whether the DMO decides to respond to demand with discretionary tenders (as it did this week). We continue to hold our sell UKT 4.5% 2028 Gilt to buy UKT 0.5% 2029 trade, monitoring on a z-spread basis (entered at -8bp with a target of -20bp and a stop-loss at +4bp). Current level is -8bp. Risk to the trade is a change in the tax treatment of Gilts for retail (see Back to school: tough tests this term, 5 September).
Â
 Rates - AU & NZ
Â
Â
Swap spreads in focus
Investors had lightened up on risk ahead of payrolls on our trip to Singapore and Hong Kong last week but the outlook for swap spreads against a backdrop of rising public spending in Australia was a popular topic of discussion. We continue to see public spending as a tailwind for the Australian economy over the next 6-12 months and we still like paying front-end RBA dates. Yet our fair value framework for 10y swap EFP (i.e., swap rate vs 10y ACGB futures yield) suggests more balanced risks and we recommend waiting for wider credit spreads before adding risk.
Fundamentals favour tighter swap spreads…
Investors were looking for the ideal entry point to position for bonds to cheapen vs swaps given the increase in bond supply from rising fiscal deficits. To be sure, the fundamental drivers of swap spreads suggest investors should position for tighter swap EFP. We currently see four compelling, fundamental reasons to receive swap spreads (i.e. position for cheaper bonds vs swap EFP):
- Combined state and federal fiscal deficits are set to increase by almost 80% between 24/25 and 25/26 financial years (Exhibit 19).
- Kangaroo bond issuers, who tend to receive swaps at the tenor they issue as part of their routine hedging programs, have extended out the curve (Exhibit 20). The attractiveness of issuing in AUD vs USD and rising superannuation fund demand for fixed-income paper means this trend is likely to continue for the foreseeable future (Exhibit 21).
- We see tighter basis markets as super funds' demand for cash and fixed-income products outpaces supply over the next few years. A likely reduction in major banks' HQLA portfolios should also reduce demand for hedged purchases of semis (i.e. less asset-swap paying from bank treasuries) (see Bullish on basis 29 August 2024).
- Markets are pricing in a synchronised global easing cycle and our global rates team recommends buying duration (Trades for cutting cycle: a historical comparison 05 September 2024). Although AUD rates are likely to lag any rally given the divergence between the RBA and Federal Reserve, the global rates backdrop means it's unlikely we will see corporates switching from floating to fixed-rate debt in the near term.
… but tight credit spreads are a risk
10y swap spreads are currently a little more than 1 standard deviation tighter than our fair value framework implies (Exhibit 16, Exhibit 17). The main reasons for the divergence from fair value are credit spreads (tighter than anticipated) and issuance patterns (less paying flow than anticipated), offsetting the impact from semi G-spreads (wider than anticipated) (Exhibit 18). While we see fundamental reasons for semi-G spreads to remain wide and issuance-related paying flow to remain depressed, the signal on credit risk suggests the risk/reward for receiving swap EFP is not particularly attractive.
Cyclical credit risks = wait for better levels to receive
A sudden widening of credit spreads is a tail-risk scenario. As we approach the end of the business cycle, there is a risk of deteriorating credit quality. Insofar as Australian company insolvencies are a leading indicator, the recent surge sends a negative signal. Yet BofA's Australia credit loss indicator, which was showing more acute signs of credit stress in 2023, has gradually eased over the past 6-9 months, suggesting the worst may be behind us (BofA Australian Bank Credit Loss Indicator 12 August 2024). Against this backdrop we would trade swap EFP more tactically and wait for the spread to widen to around 15-20bps before adding risk.
Â
Â
  Rates - JP
Â
Â
- We expect BoJ to reduce purchases of sub-10yr JGBs in Oct-Dec, while maintaining purchase sizes for superlong JGBs
- MoF shortened its maturity for JGB issuance at August liquidity enhancement auctions
 This is an excerpt from Japan Rates Watch,12 September 2024 |
BoJ reduction of JGB purchases likely to focus on sub-10yr maturities
During Oct-Dec Rinban operations, we expect the Bank of Japan (BoJ) to reduce purchases of JGBs with maturities up to 10 years and maintain the purchase sizes for superlong JGBs. In addition, considering that the Ministry of Finance (MoF) shortened the JGB issuance maturity at its liquidity enhancement auctions in August, the FY25 JGB issuance plan could also include reductions in the issuance of superlong JGBs and increases for JGBs with maturities up to 10 years.
Expect BoJ to maintain superlong purchases in 4Q24
The BoJ is scheduled to release its "Schedule of Outright Purchases of Japanese Government Bonds" for 4Q24 on 30 September at 5pm Japan time. The planned reduction of JGB purchases announced at the BoJ's July Monetary Policy Meeting (MPM) came as no surprise and focused on reducing purchase amounts for 1-3yr, 3-5yr, and 5-10yr issues (see Japan Watch: BoJ Review: Hawkish shift 31 July 2024). Considering that (1) BoJ's purchases vs the MoF's monthly issuance are still high in maturities up to 10yr (Exhibit 22); and (2) JGB yields have been stable since BoJ launched de-facto quantitative tightening (QT), we expect reductions of outright purchase (Rinban) operations in Oct-Dec to focus on JGBs with sub-10yr maturities, while recent purchase amounts for superlong maturities are maintained. We expect the BoJ to reduce planned monthly purchases of 1-3yr and 5-10yr JGBs by ¥100bn each and 3-5yr JGBs by ¥200bn from current amounts.
If the cutbacks are as we anticipate, BoJ monthly purchases as a percentage of issuance will be 50% for 1-3yr, 57% for 3-5yr, 58% for 5-10yr, 45% for 10-25yr, and 12% for 25yr+ maturities. Based on those figures, BoJ purchases of sub-10yr maturities as a percentage of monthly issuance will remain high, and we believe reductions of its purchases of superlong JGBs is unlikely until its purchases as a percentage of monthly issuance for sub-10yr maturities falls to around the same level as 10-25yr issues. We therefore do not foresee the BoJ scaling back purchases in the superlong zone until the start of 2025, at the earliest.
Â
Â
Potential flattening of 10-30yr JGB yield curve
Considering (1) an increase in net JGB supply would be a factor which raises yields of sub-10yr maturities; and (2) a likely focus on shorter maturities for new JGB issues, we see potential for a flattening of the 10-30yr yield curve. The current 10yr-30yr spread is c.120bp, but we believe this could narrow to c.110bp.
- According to our estimates, net JGB supply (gross issuance minus redemptions and BoJ's net purchases) will surge from ¥2.3tn in 2023 to ¥40.4tn in 2024. As noted above, the BoJ will likely reduce its purchases of JGBs with maturities of up to 10 years, while maintaining the recent sizes for purchases in the superlong zone. We therefore believe the yields with maturities up to 10yr are more likely to rise than yields on superlong bonds. We accordingly expect the upcoming JGB auctions to generate tails that will lead to a gradual rise in JGB yields.
- MoF reduced the issuance amount in its bimonthly liquidity enhancement auction of existing issues with remaining maturities of more than 15.5yrs and less than 39yrs to ¥400bn at the August 2024 auction, down from ¥500bn at previous auctions. On the other hand, at its monthly liquidity enhancement auction of existing issues with remaining maturities of more than 5yrs and less than 15.5yrs, the MoF increased the issuance amount to ¥650bn, up from ¥600bn at previous auctions. We believe these changes are aimed at (1) alleviating tight supply-demand for sub-10yr JGBs; and (2) reducing the duration in JGB issuance. Thus, the JGB issuance plan for FY25, which will be announced in late December, may include an increase in issuance of JGBs with maturities up to 10 years and a reduction in issuance of superlong JGBs.
Â
Â
  Front end - US
Â
Â
- Â Debt limit client questions rising, we update our projections. X-date should be in in summer '25, July now most likely
 This is an excerpt of US funding & debt limit: Sept '24 update |
Debt limit interest rising… it's almost that time again
Client questions on debt limit (DL) & funding impact have picked up. We update our note from May (see US funding & debt limit) following new TGA guidance, deficit profile tweaks, & recent price action. Bottom line: DL timing hasn't changed much. DL suspension period ends on Jan 1 '25. X-date likely in June or July '25 (July most likely). DL will lower TGA, increase cash in system, & temp ease funding into X-date. Post X-date TGA will rise & tighten funding. Trade = SOFR/FF curve flattener.
Debt limit background: suspension period & X-date
The debt limit, which is currently suspended, will reset to the level of UST debt outstanding on Jan 2 '25. Once at the DL Treasury will need to rely on the remaining cash in the TGA and employ an accounting tool known as "extraordinary measures" (EM). EM provides some headroom under the DL for Treasury to issue a limited amount of debt. Congress will need to raise / suspend the DL before UST cash & EM are exhausted; if no increase the US gov't will face technical default risk (i.e. "X-date").
X-date tweaks: July now most likely
To project the X-date we rely on 3 key factors: (1) TGA level (2) EM size (3) deficit size.
TGA: we update our forecast for YE TGA balance from $650b to $700b following the most recent quarterly refunding announcement. Treasury forecasts a TGA of $700b at YE '24, down from $850b at end Q3 '24. It must decline because the law prohibits TGA at DL suspension period end from being "above normal operating balances". We interpret "normal operating balances" to be in-line with 5D of UST outflows, which have recently averaged around $700b, in line with the Treasury's forecast.
EM: we leave our EM forecast little changed at $350b-500b. There is likely a 1-time EM measure available on Jun 30 of ~$119b; if UST can make it to June 30, they can likely make it through early July. The 1-time measure explains our large EM range.
Deficit: the X-date will ultimately depend on the level of deficits in 2025. We revise our monthly financing need forecast to smooth out our prior deficit forecast and align more with historical trends. If we assume a lower deficit in 1H '25, it may provide Treasury with more time before the debt limit becomes binding.
X-date: we continue to project the X-date will bind in June or July '25, with risk now skewed to July (we acknowledge high uncertainty & low confidence). We assume US election outcomes do not meaningfully impact debt limit timing since DL increases are always politically difficult votes even with unified gov't.
DL impacts: bill supply, excess liquidity, & QT timing
The DL is likely to impact bill supply, excess liquidity, & QT timing.
Bill supply: the DL will limit bill supply in 1H '25. Why? When the DL binds, Treasury cannot grow USTs outstanding. UST debt managers prefer to keep coupon auction sizes stable since they have largest duration risk; debt managers then must cut bill supply to offset coupon growth. We project bill cuts of $476b in 1H '25.
Excess liquidity: lower bills and higher liquidity from TGA drawdown should temporarily drive ON RRP take-up higher. Why? Lower bill supply will richen bills vs OIS & displace MMF investors into ON RRP. While higher ON RRP may suggest more liquidity in the system, the cash should quickly leave once the DL is resolved via a bill financed TGA rebuild. Signs of a liquidity build will be temporary.
QT timing: we expect the Fed will judge it prudent to end QT in late '24 or Q1'25 at the latest to avoid the risk of over draining. Lower TGA will temporarily create a loss of money market signal or Fed "blind spot" in their assessment of "abundant" to "ample" reserves. The Fed likely won't want to keep draining & overdo it when losing the money market signal. These DL dynamics drive our earlier vs consensus timing for QT stop at end '24; however, if Fed officials don't acknowledge these DL dynamics soon we will likely push out our QT stop timing to Q1 '25. The later the QT end in DL "blind spot", the greater the risk of over draining.
Market impact: 1H '25 stable funding, 2H '25 tighter
DL will support very different funding dynamics in 1H vs 2H '25. In 1H '25, upward funding pressure should moderate or reverse some of the recent rise in SOFR. This will be driven by lower bills outstanding & TGA drop. In 2H '25, funding markets will tighten with higher bill supply, a TGA rebuild, & Fed ON RRP drain.
To position for these dynamics our ideal expression would be a '25 SOFR/FF spread curve flattener. We expect that Mar '25 SOFR/FF will widen with bill paydowns & TGA decline while Sept '25 SOFR/FF will lag due to expectations for future TGA rebuild. The spread between these tenors is currently flat & we would target a spread of 3.5bps. However, liquidity in the Sept '25 SOFR/FF contract is thin. An alternative expression is long Mar '25 SOFR/FF vs short 1y1y SOFR/FF. This spread is currently 1bps & we recommend clients target 4bps with a stop of -1bps. Risk is an early debt limit resolution or very near term SOFR spike.
We currently prefer expressing DL dynamics as a SOFR/FF spread trade vs outright long Mar '25 SOFR/FF due to year end funding concerns. If USD funding tightens into year-end it will result in tightening pressure on SOFR/FF. We expect to have a better sense for year-end funding dynamics by mid/late October (street balance sheet tends to tighten into Oct 31 Canadian fiscal year end). If year-end funding pressure appears benign, we would have more confidence to recommend outright long Mar '25 SOFR/FF.
Bottom line: we update our DL expectations with most recent data. We still expect X-date in summer & now see it most likely in July (with elevated uncertainty). DL will lower TGA, increase cash in system, & temp ease funding into X-date. Post X-date TGA will rise & tighten funding. Trade = SOFR/FF curve flattener.
Â
 Front end - EU
Â
Â
- We expect the Eurosystem balance sheet to fall to €6.4trn by end-2024, incorporating our latest MRO/LTRO expectations as the refi-depo corridor narrows.
- We stay paid EUR FX-Sofr basis and close our 2y 3s6s widener.
This is an excerpt from Liquid Insight, 12 September 2024 |
Â
ECB balance sheet update
We forecast the Eurosystem's balance sheet to fall from €6.9trn at end-2023 to €6.4trn by end-2024 and €6.1trn by end-2025. The European Central Bank (ECB) will narrow the spread between the main refinancing (refi) and the deposit facility (depo) rate from 50bp to 15bp, effective 18 September 2024. This will be the tightest refi-depo spread since the ECB was established. Recent cross-border flows suggest that the initial main refinancing operation (MRO)/ longer-term refinancing operation (LTRO) take-up by banks in September will be between €50bn and €65bn.
The ECB's current set of open market operations will not help banks satiate demand for long-term funding, in our view. This suggests term premium will continue to build across the curve over time. But recent euro interbank offered rate (Euribor) fixings have prompted our 2y EUR 3s6s widener recommendation to breach its stop and therefore we close that recommendation.
As the ECB continues, and is set to accelerate, quantitative tightening (QT), we expect banks to rely more on central bank funding to meet their reserve demand over time. The ECB's shift to a demand driven floor system is different from the US Federal Reserve's ample reserve system: scarcity of euros vs US dollars will grow over time. We stay paid EUR FX-secured overnight financing rate (Sofr) basis.
Â
      Technicals
Â
Â
- Â Â US 2Y yield tests 3.55% (its 2023 low) and US 30Y yield test 3.94% (it's 52wk low). These levels, if broken, could extend the decline in US yields in H2. We're sympathetic to some bounce signals at key levels, but no bottom patterns yet.
US 2y & 30y yield test key levels. Big tops or big ranges?
Our base case view called for peak yield by US Memorial Day and lower yields thereafter. We look at the charts of US yields below and see potential for big tops, rather than ranges, as the pendulum swings from up to sideways and then to down. This is part of the reason why we advocated for being long USTs by Memorial Day and buying dips in H2. Now we see US 2Y and 30Y yield teetering on a cliff edge of 3.55% and 3.94%, respectively, as we approach the Fed meeting next week. US 5Y is getting close to its level of 3.20%. The 10Y yield has already made new 52wk lows, but its 2023 lows are still a bit lower at 3.25%. We're sympathetic to some short-term signals that suggest yields have come a long way and may see a bounce higher, such as oscillator divergences and a TD Sequential 13. Usually yields form bottom patterns and/or longs capitulate to provide substance to refute tops/favor ranges. For now, our medium-term bias remains.
Â
 Rates Alpha trade recommendationsÂ
Â
Â
Â
 Global rates forecasts
Â
 Appendix: Common acronyms
Â
Options Risk Statement
Potential Risk at Expiry & Options Limited Duration Risk
Unlike owning or shorting a stock, employing any listed options strategy is by definition governed by a finite duration. The most severe risks associated with general options trading are total loss of capital invested and delivery/assignment risk, all of which can occur in a short period.
Investor suitability
The use of standardized options and other related derivatives instruments are considered unsuitable for many investors. Investors considering such strategies are encouraged to become familiar with the "Characteristics and Risks of Standardized Options" (an OCC authored white paper on options risks). U.S. investors should consult with a FINRA Registered Options Principal.
For detailed information regarding risks involved with investing in listed options: http://www.theocc.com/about/publications/character-risks.jsp
Â
I, Ralf Preusser, CFA, hereby certify that the views expressed in this research report accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the specific recommendations or view expressed in this research report.
Â
 Important Disclosures
Â
BofA Global Research Credit Opinion Key
BofA Global Research provides recommendations on an issuer's bonds (including corporate and sovereign external debt securities), loans, capital securities, equity preferreds and CDS as described below. Convertible securities are not rated. An issuer level recommendation may also be provided for an issuer as explained below. BofA Global Research credit recommendations are assigned using a three-month time horizon.
Issuer Recommendations: If an issuer credit recommendation is provided, it is applicable to bonds and capital securities of the issuer except bonds and capital securities specifically referenced in the report with a different credit recommendation. Where there is no issuer credit recommendation, only individual bonds and capital securities with specific recommendations are covered. Loans, CDS and equity preferreds are rated separately and issuer recommendations do not apply to them.
Â
BofA Global Research credit recommendations are assigned using a three-month time horizon:
Overweight: Spreads and /or excess returns are likely to outperform the relevant and comparable market over the next three months.
Marketweight: Spreads and/or excess returns are likely to perform in-line with the relevant and comparable market over the next three months.
Underweight: Spreads and/or excess returns are likely to underperform the relevant and comparable market over the next three months.
Â
BofA Global Research uses the following rating system with respect to Credit Default Swaps (CDS):
Buy Protection: Buy CDS, therefore going short credit risk.
Neutral: No purchase or sale of CDS is recommended.
Sell Protection: Sell CDS, therefore going long credit risk.
Â
One or more analysts contributing to this report owns bonds of the covered issuer: UK
BofAS or an affiliate was a manager of a public offering of securities of this issuer within the last 12 months: France, Germany, Ile de France, Italy, UK.
The issuer is or was, within the last 12 months, an investment banking client of BofAS and/or one or more of its affiliates: France, Germany, Ile de France, Italy, UK.
BofAS or an affiliate has received compensation from the issuer for non-investment banking services or products within the past 12 months: France, Germany, Italy, Spain, UK.
The issuer is or was, within the last 12 months, a non-securities business client of BofAS and/or one or more of its affiliates: France, Germany, Italy, Spain, UK.
BofAS or an affiliate has received compensation for investment banking services from this issuer within the past 12 months: France, Germany, Ile de France, Italy, UK.
BofAS or an affiliate expects to receive or intends to seek compensation for investment banking services from this issuer or an affiliate of the issuer within the next three months: France, Germany, Italy, UK.
BofAS or one of its affiliates has a significant financial interest in the fixed income instruments of the issuer. If this report was issued on or after the 15th day of the month, it reflects a significant financial interest on the last day of the previous month. Reports issued before the 15th day of the month reflect a significant financial interest at the end of the second month preceding the report: France, Germany.
BofAS or one of its affiliates trades or may trade as principal in the debt securities (or in related derivatives) that are the subject of this research report: France, Germany, Ile de France, Italy, Spain, UK.
The issuer is or was, within the last 12 months, a securities business client (non-investment banking) of BofAS and/or one or more of its affiliates: France, Germany, Italy, Spain, UK.
Due to the nature of the market for derivative securities, the issuers or securities recommended or discussed in this report are not continuously followed. Accordingly, investors must regard this report as providing stand-alone analysis and should not expect continuing analysis or additional reports relating to such issuers and/or securities.
Due to the nature of strategic analysis, the issuers or securities recommended or discussed in this report are not continuously followed. Accordingly, investors must regard this report as providing stand-alone analysis and should not expect continuing analysis or additional reports relating to such issuers and/or securities.
Due to the nature of technical analysis, the issuers or securities recommended or discussed in this report are not continuously followed. Accordingly, investors must regard this report as providing stand-alone analysis and should not expect continuing analysis or additional reports relating to such issuers and/or securities.
BofA Global Research personnel (including the analyst(s) responsible for this report) receive compensation based upon, among other factors, the overall profitability of Bank of America Corporation, including profits derived from investment banking. The analyst(s) responsible for this report may also receive compensation based upon, among other factors, the overall profitability of the Bank's sales and trading businesses relating to the class of securities or financial instruments for which such analyst is responsible.
BofA Securities fixed income analysts regularly interact with sales and trading desk personnel in connection with their research, including to ascertain pricing and liquidity in the fixed income markets.
Other Important Disclosures
Prices are indicative and for information purposes only. Except as otherwise stated in the report, for any recommendation in relation to an equity security, the price referenced is the publicly traded price of the security as of close of business on the day prior to the date of the report or, if the report is published during intraday trading, the price referenced is indicative of the traded price as of the date and time of the report and in relation to a debt security (including equity preferred and CDS), prices are indicative as of the date and time of the report and are from various sources including BofA Securities trading desks.
The date and time of completion of the production of any recommendation in this report shall be the date and time of dissemination of this report as recorded in the report timestamp.
Â
​This report may refer to fixed income securities or other financial instruments that may not be offered or sold in one or more states or jurisdictions, or to certain categories of investors, including retail investors. Readers of this report are advised that any discussion, recommendation or other mention of such instruments is not a solicitation or offer to transact in such instruments. Investors should contact their BofA Securities representative or Merrill Global Wealth Management financial advisor for information relating to such instruments.
Rule 144A securities may be offered or sold only to persons in the U.S. who are Qualified Institutional Buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended.
​SECURITIES OR OTHER FINANCIAL INSTRUMENTS DISCUSSED HEREIN MAY BE RATED BELOW INVESTMENT GRADE AND SHOULD THEREFORE ONLY BE CONSIDERED FOR INCLUSION IN ACCOUNTS QUALIFIED FOR SPECULATIVE INVESTMENT.
Recipients who are not institutional investors or market professionals should seek the advice of their independent financial advisor before considering information in this report in connection with any investment decision, or for a necessary explanation of its contents.
The securities or other financial instruments discussed in this report may be traded over-the-counter. Retail sales and/or distribution of this report may be made only in states where these instruments are exempt from registration or have been qualified for sale.
Officers of BofAS or one or more of its affiliates (other than research analysts) may have a financial interest in securities of the issuer(s) or in related investments.
This report, and the securities or other financial instruments discussed herein, may not be eligible for distribution or sale in all countries or to certain categories of investors, including retail investors.
Refer to BofA Global Research policies relating to conflicts of interest.
"BofA Securities" includes BofA Securities, Inc. ("BofAS") and its affiliates. Investors should contact their BofA Securities representative or Merrill Global Wealth Management financial advisor if they have questions concerning this report or concerning the appropriateness of any investment idea described herein for such investor. "BofA Securities" is a global brand for BofA Global Research.
Information relating to Non-US affiliates of BofA Securities and Distribution of Affiliate Research Reports:
​​BofAS and/or Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S") may in the future distribute, information of the following non-US affiliates in the US (short name: legal name, regulator): Merrill Lynch (South Africa): Merrill Lynch South Africa (Pty) Ltd., regulated by The Financial Service Board; MLI (UK): Merrill Lynch International, regulated by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA); BofASE (France): BofA Securities Europe SA is authorized by the Autorité de Contrôle Prudentiel et de Résolution (ACPR) and regulated by the ACPR and the Autorité des Marchés Financiers (AMF). BofA Securities Europe SA ("BofASE") with registered address at 51, rue La Boétie, 75008 Paris is registered under no 842 602 690 RCS Paris. In accordance with the provisions of French Code Monétaire et Financier (Monetary and Financial Code), BofASE is an établissement de crédit et d'investissement (credit and investment institution) that is authorised and supervised by the European Central Bank and the Autorité de Contrôle Prudentiel et de Résolution (ACPR) and regulated by the ACPR and the Autorité des Marchés Financiers. BofASE's share capital can be found at www.bofaml.com/BofASEdisclaimer; BofA Europe (Milan): Bank of America Europe Designated Activity Company, Milan Branch, regulated by the Bank of Italy, the European Central Bank (ECB) and the Central Bank of Ireland (CBI); BofA Europe (Frankfurt): Bank of America Europe Designated Activity Company, Frankfurt Branch regulated by BaFin, the ECB and the CBI; BofA Europe (Madrid): Bank of America Europe Designated Activity Company, Sucursal en España, regulated by the Bank of Spain, the ECB and the CBI; Merrill Lynch (Australia): Merrill Lynch Equities (Australia) Limited, regulated by the Australian Securities and Investments Commission; Merrill Lynch (Hong Kong): Merrill Lynch (Asia Pacific) Limited, regulated by the Hong Kong Securities and Futures Commission (HKSFC); Merrill Lynch (Singapore): Merrill Lynch (Singapore) Pte Ltd, regulated by the Monetary Authority of Singapore (MAS); Merrill Lynch (Canada): Merrill Lynch Canada Inc, regulated by the Canadian Investment Regulatory Organization; Merrill Lynch (Mexico): Merrill Lynch Mexico, SA de CV, Casa de Bolsa, regulated by the Comisión Nacional Bancaria y de Valores; BofAS Japan: BofA Securities Japan Co., Ltd., regulated by the Financial Services Agency; Merrill Lynch (Seoul): Merrill Lynch International, LLC Seoul Branch, regulated by the Financial Supervisory Service; Merrill Lynch (Taiwan): Merrill Lynch Securities (Taiwan) Ltd., regulated by the Securities and Futures Bureau; BofAS India: BofA Securities India Limited, regulated by the Securities and Exchange Board of India (SEBI); Merrill Lynch (Israel): Merrill Lynch Israel Limited, regulated by Israel Securities Authority; Merrill Lynch (DIFC): Merrill Lynch International (DIFC Branch), regulated by the Dubai Financial Services Authority (DFSA); Merrill Lynch (Brazil): Merrill Lynch S.A. Corretora de TÃtulos e Valores Mobiliários, regulated by Comissão de Valores Mobiliários; Merrill Lynch KSA Company: Merrill Lynch Kingdom of Saudi Arabia Company, regulated by the Capital Market Authority.​
This information: has been approved for publication and is distributed in the United Kingdom (UK) to professional clients and eligible counterparties (as each is defined in the rules of the FCA and the PRA) by MLI (UK), which is authorized by the PRA and regulated by the FCA and the PRA - details about the extent of our regulation by the FCA and PRA are available from us on request; has been approved for publication and is distributed in the European Economic Area (EEA) by BofASE (France), which is authorized by the ACPR and regulated by the ACPR and the AMF; has been considered and distributed in Japan by BofAS Japan, a registered securities dealer under the Financial Instruments and Exchange Act in Japan, or its permitted affiliates; is issued and distributed in Hong Kong by Merrill Lynch (Hong Kong) which is regulated by HKSFC; is issued and distributed in Taiwan by Merrill Lynch (Taiwan); is issued and distributed in India by BofAS India; and is issued and distributed in Singapore to institutional investors and/or accredited investors (each as defined under the Financial Advisers Regulations) by Merrill Lynch (Singapore) (Company Registration No 198602883D). Merrill Lynch (Singapore) is regulated by MAS. Merrill Lynch Equities (Australia) Limited (ABN 65 006 276 795), AFS License 235132 (MLEA) distributes this information in Australia only to 'Wholesale' clients as defined by s.761G of the Corporations Act 2001. With the exception of Bank of America N.A., Australia Branch, neither MLEA nor any of its affiliates involved in preparing this information is an Authorised Deposit-Taking Institution under the Banking Act 1959 nor regulated by the Australian Prudential Regulation Authority. No approval is required for publication or distribution of this information in Brazil and its local distribution is by Merrill Lynch (Brazil) in accordance with applicable regulations. Merrill Lynch (DIFC) is authorized and regulated by the DFSA. Information prepared and issued by Merrill Lynch (DIFC) is done so in accordance with the requirements of the DFSA conduct of business rules. BofA Europe (Frankfurt) distributes this information in Germany and is regulated by BaFin, the ECB and the CBI. BofA Securities entities, including BofA Europe and BofASE (France), may outsource/delegate the marketing and/or provision of certain research services or aspects of research services to other branches or members of the BofA Securities group. You may be contacted by a different BofA Securities entity acting for and on behalf of your service provider where permitted by applicable law. This does not change your service provider. Please refer to the Electronic Communications Disclaimers for further information.
​This information has been prepared and issued by BofAS and/or one or more of its non-US affiliates. The author(s) of this information may not be licensed to carry on regulated activities in your jurisdiction and, if not licensed, do not hold themselves out as being able to do so. BofAS and/or MLPF&S is the distributor of this information in the US and accepts full responsibility for information distributed to BofAS and/or MLPF&S clients in the US by its non-US affiliates. Any US person receiving this information and wishing to effect any transaction in any security discussed herein should do so through BofAS and/or MLPF&S and not such foreign affiliates. Hong Kong recipients of this information should contact Merrill Lynch (Asia Pacific) Limited in respect of any matters relating to dealing in securities or provision of specific advice on securities or any other matters arising from, or in connection with, this information. Singapore recipients of this information should contact Merrill Lynch (Singapore) Pte Ltd in respect of any matters arising from, or in connection with, this information. For clients that are not accredited investors, expert investors or institutional investors Merrill Lynch (Singapore) Pte Ltd accepts full responsibility for the contents of this information distributed to such clients in Singapore.
General Investment Related Disclosures:
Taiwan Readers: Neither the information nor any opinion expressed herein constitutes an offer or a solicitation of an offer to transact in any securities or other financial instrument. No part of this report may be used or reproduced or quoted in any manner whatsoever in Taiwan by the press or any other person without the express written consent of BofA Securities.
This document provides general information only, and has been prepared for, and is intended for general distribution to, BofA Securities clients. Neither the information nor any opinion expressed constitutes an offer or an invitation to make an offer, to buy or sell any securities or other financial instrument or any derivative related to such securities or instruments (e.g., options, futures, warrants, and contracts for differences). This document is not intended to provide personal investment advice and it does not take into account the specific investment objectives, financial situation and the particular needs of, and is not directed to, any specific person(s). This document and its content do not constitute, and should not be considered to constitute, investment advice for purposes of ERISA, the US tax code, the Investment Advisers Act or otherwise. Investors should seek financial advice regarding the appropriateness of investing in financial instruments and implementing investment strategies discussed or recommended in this document and should understand that statements regarding future prospects may not be realized. Any decision to purchase or subscribe for securities in any offering must be based solely on existing public information on such security or the information in the prospectus or other offering document issued in connection with such offering, and not on this document.
Securities and other financial instruments referred to herein, or recommended, offered or sold by BofA Securities, are not insured by the Federal Deposit Insurance Corporation and are not deposits or other obligations of any insured depository institution (including, Bank of America, N.A.). Investments in general and, derivatives, in particular, involve numerous risks, including, among others, market risk, counterparty default risk and liquidity risk. No security, financial instrument or derivative is suitable for all investors. Digital assets are extremely speculative, volatile and are largely unregulated. In some cases, securities and other financial instruments may be difficult to value or sell and reliable information about the value or risks related to the security or financial instrument may be difficult to obtain. Investors should note that income from such securities and other financial instruments, if any, may fluctuate and that price or value of such securities and instruments may rise or fall and, in some cases, investors may lose their entire principal investment. Past performance is not necessarily a guide to future performance. Levels and basis for taxation may change.
BofA Securities is aware that the implementation of the ideas expressed in this report may depend upon an investor's ability to "short" securities or other financial instruments and that such action may be limited by regulations prohibiting or restricting "shortselling" in many jurisdictions. Investors are urged to seek advice regarding the applicability of such regulations prior to executing any short idea contained in this report.
This report may contain a trading idea or recommendation which highlights a specific identified near-term catalyst or event impacting a security, issuer, industry sector or the market generally that presents a transaction opportunity, but does not have any impact on the analyst's particular "Overweight" or "Underweight" rating (which is based on a three month trade horizon). Trading ideas and recommendations may differ directionally from the analyst's rating on a security or issuer because they reflect the impact of a near-term catalyst or event.
Foreign currency rates of exchange may adversely affect the value, price or income of any security or financial instrument mentioned in this report. Investors in such securities and instruments effectively assume currency risk.
BofAS or one of its affiliates is a regular issuer of traded financial instruments linked to securities that may have been recommended in this report. BofAS or one of its affiliates may, at any time, hold a trading position (long or short) in the securities and financial instruments discussed in this report.
BofA Securities, through business units other than BofA Global Research, may have issued and may in the future issue trading ideas or recommendations that are inconsistent with, and reach different conclusions from, the information presented herein. Such ideas or recommendations may reflect different time frames, assumptions, views and analytical methods of the persons who prepared them, and BofA Securities is under no obligation to ensure that such other trading ideas or recommendations are brought to the attention of any recipient of this information.
In the event that the recipient received this information pursuant to a contract between the recipient and BofAS for the provision of research services for a separate fee, and in connection therewith BofAS may be deemed to be acting as an investment adviser, such status relates, if at all, solely to the person with whom BofAS has contracted directly and does not extend beyond the delivery of this report (unless otherwise agreed specifically in writing by BofAS). If such recipient uses the services of BofAS in connection with the sale or purchase of a security referred to herein, BofAS may act as principal for its own account or as agent for another person. BofAS is and continues to act solely as a broker-dealer in connection with the execution of any transactions, including transactions in any securities referred to herein.
Copyright and General Information:
Copyright 2024 Bank of America Corporation. All rights reserved. iQdatabase® is a registered service mark of Bank of America Corporation. This information is prepared for the use of BofA Securities clients and may not be redistributed, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of BofA Securities. BofA Global Research information is distributed simultaneously to internal and client websites and other portals by BofA Securities and is not publicly-available material. Any unauthorized use or disclosure is prohibited. Receipt and review of this information constitutes your agreement not to redistribute, retransmit, or disclose to others the contents, opinions, conclusion, or information contained herein (including any investment recommendations, estimates or price targets) without first obtaining express permission from an authorized officer of BofA Securities.
Materials prepared by BofA Global Research personnel are based on public information. Facts and views presented in this material have not been reviewed by, and may not reflect information known to, professionals in other business areas of BofA Securities, including investment banking personnel. BofA Securities has established information barriers between BofA Global Research and certain business groups. As a result, BofA Securities does not disclose certain client relationships with, or compensation received from, such issuers. To the extent this material discusses any legal proceeding or issues, it has not been prepared as nor is it intended to express any legal conclusion, opinion or advice. Investors should consult their own legal advisers as to issues of law relating to the subject matter of this material. BofA Global Research personnel's knowledge of legal proceedings in which any BofA Securities entity and/or its directors, officers and employees may be plaintiffs, defendants, co-defendants or co-plaintiffs with or involving issuers mentioned in this material is based on public information. Facts and views presented in this material that relate to any such proceedings have not been reviewed by, discussed with, and may not reflect information known to, professionals in other business areas of BofA Securities in connection with the legal proceedings or matters relevant to such proceedings.
This information has been prepared independently of any issuer of securities mentioned herein and not in connection with any proposed offering of securities or as agent of any issuer of any securities. None of BofAS any of its affiliates or their research analysts has any authority whatsoever to make any representation or warranty on behalf of the issuer(s). BofA Global Research policy prohibits research personnel from disclosing a recommendation, investment rating, or investment thesis for review by an issuer prior to the publication of a research report containing such rating, recommendation or investment thesis.
Any information relating to sustainability in this material is limited as discussed herein and is not intended to provide a comprehensive view on any sustainability claim with respect to any issuer or security.
Any information relating to the tax status of financial instruments discussed herein is not intended to provide tax advice or to be used by anyone to provide tax advice. Investors are urged to seek tax advice based on their particular circumstances from an independent tax professional.
The information herein (other than disclosure information relating to BofA Securities and its affiliates) was obtained from various sources and we do not guarantee its accuracy. This information may contain links to third-party websites. BofA Securities is not responsible for the content of any third-party website or any linked content contained in a third-party website. Content contained on such third-party websites is not part of this information and is not incorporated by reference. The inclusion of a link does not imply any endorsement by or any affiliation with BofA Securities. Access to any third-party website is at your own risk, and you should always review the terms and privacy policies at third-party websites before submitting any personal information to them. BofA Securities is not responsible for such terms and privacy policies and expressly disclaims any liability for them.
All opinions, projections and estimates constitute the judgment of the author as of the date of publication and are subject to change without notice. Prices also are subject to change without notice. BofA Securities is under no obligation to update this information and BofA Securities ability to publish information on the subject issuer(s) in the future is subject to applicable quiet periods. You should therefore assume that BofA Securities will not update any fact, circumstance or opinion contained herein.
Certain outstanding reports or investment opinions relating to securities, financial instruments and/or issuers may no longer be current. Always refer to the most recent research report relating to an issuer prior to making an investment decision.
In some cases, an issuer may be classified as Restricted or may be Under Review or Extended Review. In each case, investors should consider any investment opinion relating to such issuer (or its security and/or financial instruments) to be suspended or withdrawn and should not rely on the analyses and investment opinion(s) pertaining to such issuer (or its securities and/or financial instruments) nor should the analyses or opinion(s) be considered a solicitation of any kind. Sales persons and financial advisors affiliated with BofAS or any of its affiliates may not solicit purchases of securities or financial instruments that are Restricted or Under Review and may only solicit securities under Extended Review in accordance with firm policies.
Neither BofA Securities nor any officer or employee of BofA Securities accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this information.
Â
Research AnalystsEurope Ralf Preusser, CFA Rates Strategist MLI (UK)  Mark Capleton Rates Strategist MLI (UK)  Sphia Salim Rates Strategist MLI (UK)  Ronald Man Rates Strategist MLI (UK)  Erjon Satko Rates Strategist BofASE (France)  Agne Stengeryte Rates Strategist MLI (UK)  US Ralph Axel Rates Strategist BofAS  Bruno Braizinha, CFA Rates Strategist BofAS  Mark Cabana, CFA Rates Strategist BofAS  Paul Ciana, CMT Technical Strategist BofAS  Katie Craig Rates Strategist BofAS  Meghan Swiber, CFA Rates Strategist BofAS  Anna (Caiyi) Zhang Rates Strategist BofAS  Pac Rim Shusuke Yamada, CFA FX/Rates Strategist BofAS Japan  Tomonobu Yamashita Rates Strategist BofAS Japan  Oliver Levingston Rates Strategist Merrill Lynch (Australia)  Trading ideas and investment strategies discussed herein may give rise to significant risk and are not suitable for all investors. Investors should have experience in relevant markets and the financial resources to absorb any losses arising from applying these ideas or strategies. |